JP2020504138A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504138A5 JP2020504138A5 JP2019536978A JP2019536978A JP2020504138A5 JP 2020504138 A5 JP2020504138 A5 JP 2020504138A5 JP 2019536978 A JP2019536978 A JP 2019536978A JP 2019536978 A JP2019536978 A JP 2019536978A JP 2020504138 A5 JP2020504138 A5 JP 2020504138A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- intravenous infusion
- administered
- cationic liposome
- gemcitabine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022146962A JP2022180464A (ja) | 2017-01-05 | 2022-09-15 | 膵癌の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762442636P | 2017-01-05 | 2017-01-05 | |
| US62/442,636 | 2017-01-05 | ||
| PCT/CN2018/071312 WO2018127082A1 (en) | 2017-01-05 | 2018-01-04 | Treatment of pancreatic cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022146962A Division JP2022180464A (ja) | 2017-01-05 | 2022-09-15 | 膵癌の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020504138A JP2020504138A (ja) | 2020-02-06 |
| JP2020504138A5 true JP2020504138A5 (cg-RX-API-DMAC7.html) | 2021-02-18 |
Family
ID=62789060
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536978A Pending JP2020504138A (ja) | 2017-01-05 | 2018-01-04 | 膵癌の治療 |
| JP2022146962A Pending JP2022180464A (ja) | 2017-01-05 | 2022-09-15 | 膵癌の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022146962A Pending JP2022180464A (ja) | 2017-01-05 | 2022-09-15 | 膵癌の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20190380994A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3565530B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2020504138A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20190103304A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110267650A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018205544B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019013983A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3049183A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL267613B2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2019008132A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI852903B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018127082A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11040027B2 (en) | 2017-01-17 | 2021-06-22 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| CN110974954B (zh) * | 2019-12-24 | 2021-03-16 | 珠海丽凡达生物技术有限公司 | 一种用于增强核酸疫苗免疫效果的脂质纳米颗粒及其制备方法 |
| EP4659741A1 (en) * | 2023-01-31 | 2025-12-10 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Use of paclitaxel cationic liposome in treating tumors |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW197439B (cg-RX-API-DMAC7.html) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| WO1993010076A1 (en) | 1991-11-22 | 1993-05-27 | The University Of Mississippi | Synthesis and optical resolution of the taxol side chain and related compounds |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| AU4242993A (en) | 1992-05-21 | 1993-12-13 | Penn State Research Foundation, The | Cultured (taxus) tissues as a source of taxol, related taxanes and other novel anti-tumor/anti-viral compounds |
| US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
| US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
| US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
| CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
| FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
| FR2696458B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
| US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
| US5415869A (en) | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
| WO1998008833A1 (en) | 1996-08-26 | 1998-03-05 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
| WO1998022451A1 (en) | 1996-11-19 | 1998-05-28 | Daiichi Pharmaceutical Co., Ltd. | Taxol derivatives |
| US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| JPH1192468A (ja) | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | 新規なタキサン誘導体 |
| WO1999018113A1 (fr) | 1997-10-08 | 1999-04-15 | Bio Research Corporation Of Yokohama | Derives taxoides et leur procede de production |
| ES2331791T5 (es) | 2002-06-26 | 2016-01-21 | Medigene Ag | Método de producción de una preparación catiónica de liposomas que comprende un compuesto lipófilo |
| WO2005039533A1 (en) * | 2003-10-15 | 2005-05-06 | Medigene Ag | Method of administering cationic liposomes comprising an active drug |
| CA2601067A1 (en) * | 2005-05-04 | 2006-11-09 | Medigene Ag | Method of administering a cationic liposomal preparation comprising paclitaxel |
| CA2646156C (en) * | 2006-03-22 | 2016-05-24 | Medigene Ag | Treatment of triple receptor negative breast cancer |
| CN102946880A (zh) * | 2010-04-23 | 2013-02-27 | 尼基制药公司 | 治疗胰腺癌的方法 |
| TWI760319B (zh) * | 2015-12-30 | 2022-04-11 | 杏國新藥股份有限公司 | 乳癌治療 |
| AU2017324947A1 (en) * | 2016-09-06 | 2019-03-28 | Mayo Foundation For Medical Education And Research | Paclitaxel-albumin-binding agent compositions and methods for using and making the same |
-
2018
- 2018-01-03 TW TW107100183A patent/TWI852903B/zh active
- 2018-01-04 IL IL267613A patent/IL267613B2/en unknown
- 2018-01-04 US US16/475,524 patent/US20190380994A1/en not_active Abandoned
- 2018-01-04 EP EP18735805.6A patent/EP3565530B1/en active Active
- 2018-01-04 CA CA3049183A patent/CA3049183A1/en active Pending
- 2018-01-04 WO PCT/CN2018/071312 patent/WO2018127082A1/en not_active Ceased
- 2018-01-04 CN CN201880005488.3A patent/CN110267650A/zh active Pending
- 2018-01-04 JP JP2019536978A patent/JP2020504138A/ja active Pending
- 2018-01-04 KR KR1020197022857A patent/KR20190103304A/ko not_active Ceased
- 2018-01-04 MX MX2019008132A patent/MX2019008132A/es unknown
- 2018-01-04 BR BR112019013983A patent/BR112019013983A2/pt not_active Application Discontinuation
- 2018-01-04 KR KR1020247034557A patent/KR20240154694A/ko not_active Ceased
- 2018-01-04 AU AU2018205544A patent/AU2018205544B2/en active Active
-
2019
- 2019-07-04 MX MX2022005350A patent/MX2022005350A/es unknown
-
2022
- 2022-02-24 US US17/652,409 patent/US20230035723A1/en not_active Abandoned
- 2022-09-15 JP JP2022146962A patent/JP2022180464A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023304925B2 (en) | Lipid nanoparticles using cationic cholesterol for local delivery for nucleic acid delivery | |
| ES2574231T3 (es) | Uso de liposomas catiónicos que comprenden paclitaxel | |
| JP2011507534A5 (cg-RX-API-DMAC7.html) | ||
| US9913907B2 (en) | RNAi pharmaceutical composition for suppressing expression of KRAS gene | |
| CA3215957A1 (en) | Tissue-specific nucleic acid delivery by mixed cationic lipid particles | |
| EP1553923B1 (en) | Camptothecin-carboxylate formulations | |
| JP5700909B2 (ja) | パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法 | |
| JP2022180464A (ja) | 膵癌の治療 | |
| AU2007257357A1 (en) | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof | |
| EP1817005A1 (en) | Method for loading multiple agents into delivery vehicles | |
| CN104548130A (zh) | 一种干扰Claudin3 基因表达的靶向脂质体 | |
| JPWO2017111172A1 (ja) | カチオン性脂質としての化合物 | |
| HK40117407A (en) | Lipid nanoparticles using cationic cholesterol for local delivery for nucleic acid delivery | |
| CN104548129A (zh) | 一种叶酸受体靶向的干扰Claudin3 基因表达的药物组合物 |